부산대학교 도서관

Saha, Satabdi ; Rehman, Lubna ; Rehman, Abdur ; Darbaniyan, Faezeh ; Weber, Donna M. ; Becnel, Melody ; Gaballa, Mahmoud ; Thomas, Sheeba K. ; Lee, Hans C. ; Chang, Chia-Chi ; Arora, Reetakshi ; Menges, Meghan ; Corallo, Salvatore ; Davila, Marco L. ; Locke, Frederick L. ; Tanner, Mark R. ; Neelapu, Sattva S. ; Shpall, Elizabeth J. ; Flowers, Christopher R. ; Orlowski, Robert Z. ; Jenq, Robert R. ; Jain, Michael D. ; Peterson, Christine ; Hansen, Doris K. ; Saini, Neeraj Y. ; Patel, Krina K.

In Blood Advances 22 July 2025 9(14):3429-3440

Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wei Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bataller A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Arani N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Darbaniyan F; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chien K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bouligny I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Thongon N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Urrutia S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Short N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Issa G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang W; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bueso-Ramos C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. GMontalban1@mdanderson.org.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Anfossi S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA. sanfossi@mdanderson.org.; Darbaniyan F; Department of Hematopoietic Biology & Malignancy, The University of Texas MD Anderson Cancer Center, Houston, USA.; Quinlan J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Calin S; Department of Hemopathology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Shimizu M; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Chen M; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Rausseo P; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Winters M; Department of Microbiology, Immunology and Cell Biology, West Virginia University Cancer Institute, Morgantown, USA.; Bogatenkova E; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Do KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA.; Martinez I; Department of Microbiology, Immunology and Cell Biology, West Virginia University Cancer Institute, Morgantown, USA.; Li Z; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA.; Antal L; Clinical Laboratory, Municipal Clinical Emergency Hospital, Timisoara, Romania.; Olariu TR; Clinical Laboratory, Municipal Clinical Emergency Hospital, Timisoara, Romania.; Department of Infectious Diseases, Center for Diagnosis and Study of Parasitic Diseases, Victor Babes University of Medicine and Pharmacy, Timisoara, Romania.; Wistuba I; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Calin GA; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA. gcalin@mdanderson.org.; The Non-coding RNA Center, The University of Texas MD Anderson Cancer Center, Houston, USA. gcalin@mdanderson.org.

Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE

F. Darbaniyan; G. Montalban Bravo; K. S. Chien; R. Kanagal Shamanna; K. sasaki; H. Yang; K. A. Soltysiak; Z. Li; K.-A. Do; G. Garcia-Manero

HemaSphere, Vol 6, Pp 657-658 (2022)

Prasad R; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Rehman A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Rehman L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Darbaniyan F; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Blumenberg V; Department of Medicine III, Ludwig Maximilian University of Munich University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Ludwig Maximilian University of Munich Gene Center, Ludwig Maximilian University of Munich, Munich, Germany.; German Cancer Consortium and Bavarian Center for Cancer Research, Partner Site Munich, Munich, Germany.; Schubert ML; Department of Hematology, Oncology, and Rheumatology, University Clinic Heidelberg, Heidelberg, Germany.; Mor U; Systems Immunology Department, Weizmann Institute of Science, Rehovot, Israel.; Zamir E; Division of Microbiome and Cancer, German Cancer Consortium, Heidelberg, Germany.; Schmidt S; Division of Microbiome and Cancer, German Cancer Consortium, Heidelberg, Germany.; Hayase T; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Chang CC; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; McDaniel L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Flores I; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Strati P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Nair R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Chihara D; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Fayad LE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Ahmed S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Iyer SP; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Wang M; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Jain P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Westin J; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Arora R; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Turner J; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.; Khawaja F; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX.; Wu R; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX.; Dennison JB; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX.; Menges M; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.; Hidalgo-Vargas M; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.; Reid K; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.; Davila ML; Department of Stem Cell Transplantation and Cellular Therapy, Roswell Cancer Institute, Buffalo, NY.; Dreger P; Department of Hematology, Oncology, and Rheumatology, University Clinic Heidelberg, Heidelberg, Germany.; Korell F; Department of Hematology, Oncology, and Rheumatology, University Clinic Heidelberg, Heidelberg, Germany.; Schmitt A; Department of Hematology, Oncology, and Rheumatology, University Clinic Heidelberg, Heidelberg, Germany.; Tanner MR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.; Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.; Flowers CR; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.; Hanash S; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX.; Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Schmitt M; Department of Hematology, Oncology, and Rheumatology, University Clinic Heidelberg, Heidelberg, Germany.; Subklewe M; Department of Medicine III, Ludwig Maximilian University of Munich University Hospital, Ludwig Maximilian University of Munich, Munich, Germany.; Laboratory for Translational Cancer Immunology, Ludwig Maximilian University of Munich Gene Center, Ludwig Maximilian University of Munich, Munich, Germany.; German Cancer Consortium and Bavarian Center for Cancer Research, Partner Site Munich, Munich, Germany.; Francois-Fahrmann J; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX.; Stein-Thoeringer CK; Department of Internal Medicine I, University Clinic Tüebingen, Tüebingen, Germany.; M3 Research Institute, Faculty of Medicine, University of Tüebingen, Tüebingen, Germany.; Elinav E; Systems Immunology Department, Weizmann Institute of Science, Rehovot, Israel.; Division of Microbiome and Cancer, German Cancer Consortium, Heidelberg, Germany.; Jain MD; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.; Hayase E; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Jenq RR; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.; Saini NY; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Darbaniyan F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Venugopal S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Jabbour EJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Konopleva MY; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Pierce SA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Thongon N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rodriguez-Sevilla JJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ma F; Department of Molecular, Cell and Developmental Biology, University of California Los Angeles, Los Angeles, CA, USA.; Ganan-Gomez I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yang H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kim YJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Adema V; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wildeman B; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tanaka T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Darbaniyan F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Al-Atrash G; Department of Stem Cell Transplantation and Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Dwyer K; Department of Stem Cell Transplantation and Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Song X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Colla S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: scolla@mdanderson.org.

Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

Wei Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zheng H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lockyer PP; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Darbaniyan F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Li Z; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Soltysiak KA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yang H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ganan-Gomez I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Do KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Wei Y; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ywei@mdanderson.org.; Zheng H; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Li Z; Departments of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lockyer PP; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Darbaniyan F; Departments of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kanagal-Shamanna R; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yang H; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Hammond D; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Garcia-Manero G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Ho IL; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Li CY; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhao L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Liu J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yen EY; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Dyke CA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Shah R; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Liu Z; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Çetin AO; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rössle-Str. 10, 13125 Berlin, Germany.; Chu Y; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Citron F; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Attanasio S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Corti D; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Darbaniyan F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Del Poggetto E; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Loponte S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Liu J; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Soeung M; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chen Z; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jiang S; TRACTION platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jiang H; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Inoue A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gao S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; TRACTION platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Deem A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Feng N; TRACTION platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ying H; Department of Cellular and Molecular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kim M; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Giuliani V; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rössle-Str. 10, 13125 Berlin, Germany.; Genovese G; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Futreal A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Maitra A; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Heffernan T; TRACTION platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Do KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gargiulo G; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Robert-Rössle-Str. 10, 13125 Berlin, Germany.; Draetta G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Carugo A; TRACTION platform, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lin R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Viale A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE

Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Darbaniyan F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bueso-Ramos C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Wei Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Chien K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Soltysiak KA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Routbort M; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Patel K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Medeiros LJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Darbaniyan F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Siddiqui MT; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Wei Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Yang H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Naqvi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; DiNardo C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Bose P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Verstovsek S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Bueso-Ramos C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Patel K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Do KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Montalban-Bravo G; Ma F; Thongon N; Yang H; Gomez IG; Rodriguez-Sevilla JJ; Adema V; Wildeman B; Lockyer P; Kim YJ; Tanaka T; Darbaniyan F; Pancholy S; Zhang G; Al-Atrash G; Dwyer K; Takahashi K; Garcia-Manero G; Kantarjian H; Colla S

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.; Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.; Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.; Darbaniyan F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston.; Do KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston.; Class C; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston.; Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.; Kanagal-Shamana R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston.; Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.; Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.; Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.; Cortes J; Georgia Cancer Center, Augusta.; Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.; Alvarado Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.; Chien K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.; Komrokji R; Moffitt Cancer Center, Tampa, FL.; Sekeres MA; Division of Hematology, Sylvester Cancer Center, University of Miami, Miami.; Steensma DP; Dana-Farber Cancer Institute, Boston.; DeZern A; Johns Hopkins University, Baltimore.; Roboz G; Weill Cornell Medical College, New York.; Soltysiak K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.; Yang H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.; Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.; Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.

Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2766-5526 (Electronic) Linking ISSN: 27665526 NLM ISO Abbreviation: NEJM Evid Subsets: MEDLINE

Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Darbaniyan F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ohanian M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Chien K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Short N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Alvarado Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Andreeff M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ganan-Gomez I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Colla S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Qiao W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Huang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; McCue D; Pharmacy Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Mirabella B; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: ggarciam@mdanderson.org.

Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

Darbaniyan F; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX.; Zheng H; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.; Kanagal-Shamanna R; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX.; Lockyer P; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.; Montalban-Bravo G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.; Estecio M; Department of Epigenetics and Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Houston, X.; Lu Y; Department of Epigenetics and Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Houston, X.; Soltysiak KA; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.; Chien KS; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.; Yang H; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.; Sasaki K; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.; Class C; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX; Department of Pharmaceutical Sciences, Butler University, Indianapolis, IN.; Ganan-Gomez I; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.; Do KA; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX.; Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.; Wei Y; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: ywei@mdanderson.org.

Publisher: Elsevier Science Inc Country of Publication: Netherlands NLM ID: 0402313 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2399 (Electronic) Linking ISSN: 0301472X NLM ISO Abbreviation: Exp Hematol Subsets: MEDLINE

Wei Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ywei@mdanderson.org.; Kanagal-Shamanna R; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Zheng H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bao N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lockyer PP; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Class CA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Darbaniyan F; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lu Y; Department of Epigenetic & Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lin K; Department of Epigenetic & Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Yang H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ganan-Gomez I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Soltysiak KA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Do KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Colla S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. ggarciam@mdanderson.org.

Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Kanagal-Shamanna R; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. RKanagal@mdanderson.org.; Orazi A; Texas Tech University Health Science Center, El Paso, TX, USA.; Hasserjian RP; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Arber DA; University of Chicago, Chicago, IL, USA.; Reichard K; Mayo Clinic, Rochester, MN, USA.; Hsi ED; Wake Forest Baptist Health, Winston-Salem, NC, USA.; Bagg A; Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Rogers HJ; Cleveland Clinic, Cleveland, OH, USA.; Geyer J; Weill Cornell Medical College, New York, NY, USA.; Darbaniyan F; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Do KA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Devins KM; Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Pozdnyakova O; Brigham and Women's Hospital, Boston, MA, USA.; George TI; University of Utah, Salt Lake City, UT, USA.; Cin PD; Brigham and Women's Hospital, Boston, MA, USA.; Greipp PT; Mayo Clinic, Rochester, MN, USA.; Routbort MJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel K; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Garcia-Manero G; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Verstovsek S; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medeiros LJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang SA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bueso-Ramos C; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. cbuesora@mdanderson.org.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE; PubMed not MEDLINE

Kanagal-Shamanna R; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. RKanagal@mdanderson.org.; Orazi A; Texas Tech University Health Science Center, El Paso, TX, USA.; Hasserjian RP; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Arber DA; University of Chicago, Chicago, IL, USA.; Reichard K; Mayo Clinic, Rochester, MN, USA.; Hsi ED; Wake Forest Baptist Health, Winston-Salem, NC, USA.; Bagg A; Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Rogers HJ; Cleveland Clinic, Cleveland, OH, USA.; Geyer J; Weill Cornell Medical College, New York, NY, USA.; Darbaniyan F; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Do KA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Devins KM; Hospital of the University of Pennsylvania, Philadelphia, PA, USA.; Pozdnyakova O; Brigham and Women's Hospital, Boston, MA, USA.; George TI; University of Utah, Salt Lake City, UT, USA.; Cin PD; Brigham and Women's Hospital, Boston, MA, USA.; Greipp PT; Mayo Clinic, Rochester, MN, USA.; Routbort MJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel K; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Garcia-Manero G; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Verstovsek S; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Medeiros LJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Wang SA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bueso-Ramos C; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. cbuesora@mdanderson.org.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE

Montalban-Bravo G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: gmontalban1@mdanderson.org.; Darbaniyan F; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Kanagal-Shamanna R; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Ganan-Gomez I; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Class CA; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States; Butler University, Indianapolis, IN, United States.; Sasaki K; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Naqvi K; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Wei Y; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Yang H; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Soltysiak KA; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Chien KS; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Bueso-Ramos C; Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Do KA; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Kantarjian H; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Garcia-Manero G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE